Mathers, CD, Fat, DM, Boerma, JT, The global burden of disease: 2004 update. World Health Organization, 2008.
Guest, JF, Morris, A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. European Respiratory Journal
1997; 10: 1530–1534.
File, TM Jr., Marrie, TJ. Burden of community-acquired pneumonia in North American adults. Postgraduate Medicine
2010; 122: 130–141.
Lave, JR, et al.
Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas. Journal of General Internal Medicine
1996; 11: 415–421.
Marrie, TJ, et al.
Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume. European Respiratory Journal
2003; 22: 148–55.
Eurich, DT, Majumdar, SR, Marrie, TJ. Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics. BMC Infectious Diseases
2012; 12: 135.
Hoo, Lee J, Hyung, Kim Y. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals. Brazilian Journal of Infectious Diseases
2012; 16: 321–328.
Ramirez, JA, Anzueto, AR. Changing needs of community-acquired pneumonia. Journal of Antimicrobial Chemotherapy
2011; 66 (Suppl. 3): 3–9.
Yende, S, et al.
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. American Journal of Respiratory and Critical Care Medicine
2008; 177: 1242–1247.
Yende, S, et al.
Influence of comorbid conditions on long-term mortality after pneumonia in older people. Journal of the American Geriatrics Society
2007; 55: 518–525.
Mortensen, EM, et al.
Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clinical Infectious Diseases
2003; 37: 1617–24.
Waterer, GW, Kessler, LA, Wunderink, RG. Medium-term survival after hospitalization with community-acquired pneumonia. American Journal of Respiratory and Critical Care Medicine
2004; 169: 910–914.
Johnstone, J, et al.
Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore)
2008; 87: 329–334.
Kaplan, V, et al.
Pneumonia: still the old man's friend?
Archives of Internal Medicine
2003; 163: 317–23.
Day, N, et al.
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. British Journal of Cancer
1999; 80 (Suppl. 1): 95–103.
Myles, PR, et al.
Pneumonia mortality in a UK general practice population cohort. European Journal of Public Health
2009; 19: 521–526.
Cox, D. Regression models and life tables. Journal of the Royal Statistical Society
1972; 34: 187–220.
Corrales-Medina, VF, et al.
Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. Journal of the American Medical Association
2015; 313: 264–274.
Bordon, J, et al.
Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest
2010; 138: 279–283.
Mendall, MA, et al.
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart
1997; 78: 273–277.
Kumar, A, et al.
Tumor necrosis factor alpha and interleukin-1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. Journal of Experimental Medicine
1996; 183: 949–958.
Mann, DL. Inflammatory mediators and the failing heart past, present, and the foreseeable future. Circulation Research
2002; 91: 988–998.
Pink, KL, Mitchell, I, Davies, HE. P17 the accuracy of a diagnosis of pneumonia in a UK teaching hospital. Thorax
2012; 67 (Suppl. 2): A71–A71.
Moellering, RC. The continuing challenge of lower respiratory tract infections. Clinical Infectious Diseases
2002; 34 (Suppl. 1): S1–S3.